Differences in clinical significance and morphologic features of Blastocystis sp subtype 3
- PMID: 20093234
- DOI: 10.1309/AJCPDOWQSL6E8DMN
Differences in clinical significance and morphologic features of Blastocystis sp subtype 3
Abstract
Blastocystis is a polymorphic intestinal parasite that is common in humans. A total of 51 asymptomatic and symptomatic patients positive for Blastocystis only were included in the study. Symptoms were mainly nonspecific gastrointestinal symptoms. Blastocystis isolates were xenically cultured and subtyped. Blastocystis species subtype 3 was the predominant subtype. Intrasubtype differences (vacuolar/amoeboid presence) in subtype 3 morphotypes were observed in 32 asymptomatic and symptomatic subtype 3 cases and could possibly be related to Blastocystis pathogenic potential. Diverse morphologic features (vacuolar transiting to amoeboid), probably reflecting the progression from an asymptomatic to a symptomatic state, were observed in an asymptomatic subtype 3 carrier who later had symptoms. Searching for amoeboid forms might be helpful to presumptively screen symptomatic patients with subtype 3 or to follow up an asymptomatic subtype 3 carrier in case symptoms become evident before antiprotozoal treatment was attempted. Further studies on the roles of morphologic features and variation within Blastocystis species subtypes as predictors of symptoms are encouraged.
Similar articles
-
Molecular epidemiology of Blastocystis infections in Turkey.Parasitol Int. 2008 Sep;57(3):300-6. doi: 10.1016/j.parint.2008.01.004. Epub 2008 Feb 13. Parasitol Int. 2008. PMID: 18337161
-
Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms.Parasitol Int. 2010 Sep;59(3):469-71. doi: 10.1016/j.parint.2010.03.009. Epub 2010 Apr 2. Parasitol Int. 2010. PMID: 20363362
-
Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite.Epidemiol Infect. 2009 Nov;137(11):1655-63. doi: 10.1017/S0950268809002672. Epub 2009 Apr 27. Epidemiol Infect. 2009. PMID: 19393117
-
Blastocystis, urticaria, and skin disorders: review of the current evidences.Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1027-1042. doi: 10.1007/s10096-019-03793-8. Epub 2019 Dec 24. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31873864
-
Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.Int J Parasitol. 2007 Jan;37(1):11-20. doi: 10.1016/j.ijpara.2006.09.009. Epub 2006 Oct 12. Int J Parasitol. 2007. PMID: 17070814 Review.
Cited by
-
Laboratory diagnosis of Blastocystis spp. in diarrheic patients.Trop Parasitol. 2015 Jan-Jun;5(1):36-41. doi: 10.4103/2229-5070.149919. Trop Parasitol. 2015. PMID: 25709951 Free PMC article.
-
Determining intestinal parasitic infections (IPIs) in inmates from Kajang Prison, Selangor, Malaysia for improved prison management.BMC Infect Dis. 2015 Oct 29;15:467. doi: 10.1186/s12879-015-1178-3. BMC Infect Dis. 2015. PMID: 26511347 Free PMC article.
-
Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro.Clin Transl Gastroenterol. 2021 Apr 9;12(4):e00325. doi: 10.14309/ctg.0000000000000325. Clin Transl Gastroenterol. 2021. PMID: 33835078 Free PMC article.
-
Blastocystis: Consensus of treatment and controversies.Trop Parasitol. 2013 Jan;3(1):35-9. doi: 10.4103/2229-5070.113901. Trop Parasitol. 2013. PMID: 23961439 Free PMC article.
-
Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis.Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):335-43. doi: 10.1007/s10096-012-1746-z. Epub 2012 Sep 21. Eur J Clin Microbiol Infect Dis. 2013. PMID: 22996007
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources